国庆
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
千寒
Lv7
3440 积分
2022-11-05 加入
最近求助
最近应助
互助留言
Prognostic analysis of lymph node resection and liver resection for T1b and T2 gallbladder cancer: a multi-center retrospective study
11小时前
求助中
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
16天前
已完结
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients
1个月前
已完结
Conversion surgery after immune checkpoint inhibitor-based combination therapy for initially unresectable hepatocellular carcinoma: A retrospective cohort study
1个月前
已完结
CircNOX4 promotes proliferation and resistance by regulating the hsa-miR-6884-5p/YWHAG Axis and ERK signaling pathway in cholangiocarcinoma
2个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
3个月前
已完结
Low level exposure to BDE-47 facilitates the development of prostate cancer through TOP2A/LDHA/lactylation positive feedback circuit
3个月前
已完结
FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2
4个月前
已完结
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
5个月前
已完结
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
5个月前
已关闭
没有进行任何应助
感谢
1个月前
帮大忙了
1个月前
感谢
3个月前
感谢
3个月前
不需要了【积分已退回】
5个月前
速度真快
5个月前
帮大忙了
5个月前
帮大忙了
5个月前
帮大忙了
7个月前
点赞
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论